Federal Register of Legislation - Australian Government

Primary content

PB 62 of 2020 Determinations/Health as made
This determination amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010) by removing one brand of two pharmaceutical items, one with a specific pack size that will no longer be PBS listed on 1 July 2020.
Administered by: Health
Registered 30 Jun 2020

 

PB 62 of 2020

 

National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 5)

 

National Health Act 1953

___________________________________________________________________________

 

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

 

Dated    29   June 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 


_________________________________________________________________________

1          Name of Instrument

(1)          This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 5).

(2)          This Instrument may also be cited as PB 62 of 2020.

2          Commencement

This Instrument commences on 1 July 2020.

3          Amendment of National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

 


Schedule 1     Amendments

[1]   Schedule 1, entry for Clonazepam

Omit:

Clonazepam

Tablet 2 mg

Oral

Rivotril

100

9.96

12.10

 

Tablet 500 mcg

Oral

Rivotril

  50

2.65

  3.51

 

 

 

 

100

 

  7.01

Substitute:

Clonazepam

Tablet 500 mcg

Oral

Rivotril

  50

2.65

  3.51